Latest Shareholder Voting News

Sigma Healthcare has achieved unanimous shareholder approval for its proposed merger with Chemist Warehouse, marking a pivotal step toward reshaping Australia's pharmaceutical retail landscape. The merger now awaits final court approval, with implementation anticipated in mid-February 2025.

Sigma Healthcare has successfully passed all key resolutions at its extraordinary general meeting, clearing a major hurdle for its proposed merger with Chemist Warehouse. The deal now awaits final court approval, with implementation expected in February.

ReNu Energy has raised $500,000 through loan notes that may convert into shares and options pending shareholder approval, aiming to bolster working capital.

Entertainment Rewards Ltd has secured a pivotal amendment to its $22.5 million convertible loan, slashing interest costs and extending repayment terms to bolster its financial flexibility.

Enova Mining has secured $1.5 million through a two-tranche placement to fund key project developments and exploration activities across its lithium and rare earth assets in Brazil and Australia.

Dropsuite Limited has entered a binding Scheme Implementation Deed with NinjaOne for a $420 million all-cash acquisition at $5.90 per share, representing a significant premium to recent trading prices. The deal, supported unanimously by Dropsuite’s board and largest shareholder, awaits shareholder and regulatory approvals.

Leeuwin Metals Limited (ASX:LM1) has secured a transformative acquisition of the Marda Gold Project, significantly enhancing its portfolio with a high-grade gold asset in Western Australia. The company also announced a $3.25 million capital raising to fund extensive exploration across its Australian and Canadian projects.

Auswide Bank has secured Treasurer approval for MyState Bank’s acquisition via a scheme of arrangement, setting the stage for a pivotal shareholder vote in early February.

InhaleRx has corrected its quarterly report and revealed a $38.5 million funding deal to fast-track clinical trials for its inhaled therapies targeting breakthrough cancer pain and panic disorder, aiming for FDA approval.

Bod Science Limited reports a modest net cash inflow of $51,000 for Q2 FY2025, supported by increased customer receipts and intellectual property sales, while navigating a complex Deed of Company Arrangement and pending acquisition.

Amcor plc has taken a pivotal step in its proposed merger with Berry Global by filing the definitive joint proxy statement with the SEC, setting the stage for shareholder votes in February. Integration planning is well underway as both companies prepare to unite their packaging expertise.

Amcor plc and Berry Global Group, Inc. have entered into a definitive all-stock merger agreement, positioning the combined entity as a global leader in consumer and healthcare packaging with expected annual synergies of $650 million.